# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 4051 results.
Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
Status: Completed
Last Changed: Jun 03, 2016
First Received: Dec 15, 2011
Disease(s): Hepatitis C
Intervention(s): Daclatasvir, Telaprevir, Peginterferon alfa-2a, Ribavirin
Locations: The Kirklin Clinic, Birmingham, Alabama, United States
Mayo Clinic Arizona, Phoenix, Arizona, United States
Va Long Beach Healthcare System, Long Beach, California, United States
Medical Associates Research Group, San Diego, California, United States
Yale University School Of Medicine, New Haven, Connecticut, United States
... and 87 other locations.
Hepatitis B Seroepidemiology Among Young Adults
Status: Unknown status
Last Changed: Oct 31, 2013
First Received: Oct 31, 2013
Disease(s): Hepatitis B
Locations: National Taiwan University Hospital, Taipei, Taiwan
Increasing Hepatitis B Screening Among Korean Church Attendees
Status: Completed
Last Changed: Nov 28, 2016
First Received: Sep 26, 2008
Disease(s): Hepatitis B
Intervention(s): Educational Small Group Session
Locations: UCLA, Division of Cancer Prevenion and Control Research, Los Angeles, California, United States
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients
Status: Recruiting
Last Changed: Oct 20, 2020
First Received: Oct 21, 2019
Disease(s): Hepatitis B, Chronic
Intervention(s): Recombinant anti-programmed death-1 (PD-1) humanized monoclonal antibody, Nucleoside/nucleotide analogues
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
China Medical University Hospital, Taichung, Taiwan
National Taiwan University Hospita, Taipei, Taiwan
The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
Status: Suspended
Last Changed: Jul 14, 2020
First Received: Jan 31, 2014
Disease(s): Autoimmune Hepatitis
Intervention(s): Low Salt Diet, Liberal salt diet
Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil
Status: Completed
Last Changed: May 08, 2017
First Received: May 16, 2016
Disease(s): Hepatitis C Virus
Locations: Goiânia, Brazil
Porto Alegre, Brazil
Porto Velho, Brazil
Recife, Brazil
Rio Branco, Brazil
... and 4 other locations.
Hepatitis B Research Network Adult Cohort Study
Status: Active, not recruiting
Last Changed: Nov 09, 2020
First Received: Dec 20, 2010
Disease(s): Hepatitis B
Locations: Cedars Sinai Medical Center, Los Angeles, California, United States
University of California Los Angeles, Los Angeles, California, United States
California Pacific Medical Center, San Francisco, California, United States
University of California San Francisco, San Francisco, California, United States
The Queen's Medial Center, Honolulu, Hawaii, United States
... and 17 other locations.
Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Status: Terminated
Last Changed: Aug 08, 2016
First Received: Mar 16, 2011
Disease(s): Hepatitis D
Intervention(s): EBP921
Locations: San Francisco, California, United States
Henry Ford Hospital, Detroit, Michigan, United States
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Status: Recruiting
Last Changed: Oct 08, 2020
First Received: May 01, 2019
Disease(s): Hepatitis B, Viral Hepatitis
Intervention(s): Tenofovir alafenamide, Entecavir
Locations: Taichung Veterans General Hospital, Taichung, Taiwan
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Status: Withdrawn
Last Changed: Mar 02, 2018
First Received: Jun 12, 2017
Disease(s): Hepatitis A
Intervention(s): Havrix®